Search

Search Constraints

You searched for: Author/Creator Vuagnat, Perrine

Search Results

1. Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities. (November 2021)

2. Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients. Issue 1 (6th January 2021)

3. Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer. (September 2020)

4. Effectiveness of a digital telemonitoring platform for cancer care of older patients: The ConnectElderlyPatientToDoctor study. Issue 3 (9th July 2022)

5. Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types. (19th February 2020)

6. Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies. (April 2020)

7. Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers. Issue 7 (27th July 2022)